CDMO niche Sever Pharma Solutions specializes in controlled release systems for highly potent drugs, offering end-to-end development and manufacturing. This positions them as a strategic partner for advanced drug delivery programs requiring integrated CDMO support.

Global footprint With manufacturing facilities in Malmö, Sweden and Putnam, CT, USA, Sever has cross-continental capabilities that can support global supply chains, regulatory localization, and regional market access for potent and specialty therapies.

Leadership updates Recent hires in senior roles including General Counsel, Vice President of Quality, VP of Operations, and CEO indicate a focus on governance, quality, and operational scaling, signaling readiness for larger collaborations and complex projects.

Strategic partnerships Active collaborations and news of ketamine implant development and other high-potent formulations suggest opportunities to expand partnerships in specialized implant and solubility enhancement programs for challenging therapeutics.

Financial potential Revenue range indicates a mid-market player with sizable project budgets. This presents opportunities for CDMO services across development, sterile fill-finish, hot melt extrusion, and polymer-based sustained release programs.